Larvol Delta - Amzell-BV-in-Collaboration-With-Amring-Pharmaceuticals-Inc-Announce-Their-Lead-Product-Has-Entered-Phase-III-Clinical-Trial-in-the-US-for-Treatment-of-Infantile-Epileptic-Disease

AMZ002 - Amzell, Amring

https://www.businesswire.com/news/home/20211119005740/en/Amzell-B.V.-in-Collaboration-With-Amring-Pharmaceuticals-Inc.-Announce-Their-Lead-Product-Has-Entered-Phase-III-Clinical-Trial-in-the-U.S.-for-Treatment-of-Infantile-Epileptic-Disease

Nov 19, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next